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Sprint Interval Training (SIT) is a potent stimulus for physiological and metabolic 
DGDSWDWLRQVFRPSDUDEOHZLWKWKRVHLQGXFHGE\WUDGLWLRQDOµDHURELF¶HQGXUDQFHWUDLQLQJThere 
has been a great deal of recent research on SIT, which may lead to increased use of this type 
of training. The purpose of the present study was to determine the acute effects of SIT on 
aspects of innate immunity not previously researched in this context. Nine males completed 
one SIT and one resting control trial in a crossover design. Blood and saliva samples were 
obtained at pre-, post- and 30 minutes post-exercise to measure blood neutrophil oxidative 
burst activity (OBA) in addition to saliva secretary IgA (s-IgA) and lysozyme. SIT induced a 
significant depression of neutrophil fMLP-stimulated OBA (±30% 30 minutes post-exercise, 
P < 0.01), PMA-stimulated OBA (±14% post-exercise, ±21% 30 minutes post-exercise, P < 
0.01) and bacterial-stimulated degranulation (±23% post-exercise, ±32% 30 minutes post-
exercise, P < 0.01) but not fMLP-then-PMA-stimulated OBA, saliva lysozyme or s-IgA 
concentrations or secretion rates (P > 0.05). The main novel finding of the present study is 
that a single session of SIT causes significant exercise-induced immunodepression of some 
neutrophil functions but mucosal immunity was not depressed.  
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Sprint Interval Training (SIT, also described as High Intensity Interval Training or HIT) has 
recently attracted a great deal of research interest. In particular, there is a growing body of 
research on the effects of Wingate-based SIT, which typically involves 3-UHSHDWHGµDOO-RXW¶
30-second Wingate tests with short recovery intervals of between 3 and 5 minutes. There is 
now substantial evidence for the physiological adaptation and performance enhancing effects 
that can be induced by this type of exercise. It has been demonstrated that relatively short-
term periods (2 weeks) of Wingate-based SIT are a potent stimulus for physiological, 
metabolic and molecular adaptations associated with enhanced functional capacity,  exercise 
performance (Burgomaster et al. 2005, 2007, 2008; Gibala et al. 2006; Gibala and McGee, 
2008), metabolic regulation and other health-related indices (Babraj et al. 2009; Richards et 
al. 2010; Whyte, Gill, and Cathcart, 2010). In many cases the magnitude of these SIT-
induced physiological adaptations are comparable with or greater than those associated with 
WUDGLWLRQDOµDHURELF¶HQGXUDQFHWUDLQLQJ (referred to hereafter as endurance training) (Gibala 
& Little, 2010; Gibala & McGee, 2008). Therefore, SIT has been proposed as a time-efficient 
exercise protocol for the enhancement of endurance performance, but also with possible 
implications for health and the prevention or management of chronic or metabolic diseases 
(such as insulin resistance and Type 2 Diabetes).  
 
Many physiological responses to SIT have been well researched and described in the 
literature. However, the immune responses to such exercise have not. The immune response 
to physical exertion is an important aspect of the physiological responses which can have 
implications for training. For example, it is well known that individuals engaged in intensive 
training regimes, particularly endurance athletes, report a higher infection incidence, 
  
especially of the upper respiratory tract, compared with their less active counterparts 
(Gleeson, 2007; Neville et al. 2008; Spence et al. 2007). It is generally accepted that this is 
attributable, at least in part, to exercise-induced alterations in immune function, termed 
exercise-induced immunodepression, and the acute response to exercise bouts are of 
significance. This includes changes in the distribution and functional capacity of 
immunocompetent cells, and effector and regulatory molecules of the immune system 
(Gleeson, 2007; Nagatomi, 2006; Nieman, 1997, 2007; Pedersen and Hoffman-Goetz, 2000). 
The magnitude and direction of exercise-induced immune perturbations are related to training 
volume and intensity, with the largest acute immune perturbations typically seen after 
prolonged exercise (Gleeson, 2007; Gleeson et al. 2004; Nieman, 1994; Spence et al. 2007). 
As the training load (or impulse) is influenced by the intensity and duration of exercise, it is 
unclear how extremely high-intensity and low volume training, such as Wingate-based SIT, 
fits within this paradigm. A small number of previous studies (Fahlman et al. 2001; Hall et al. 
2007; MacKinnon and Jenkins, 1993) have investigated the acute effects of such exercise 
bouts on mucosal immunity, with observations of compromised salivary IgA concentration 
and secretion, but there is a distinct lack of research on other aspects of the immune system. 
The author is not aware of any previous study that has assessed aspects of innate immunity 
following this type of repeated Wingate SIT. Innate immune function plays a key role in 
resistance to infection. For example, neutrophils are a key first line of defence against 
infection and populations with sub-normal neutrophil functions are known to have an 
increased infection incidence compared with healthy controls (Kowalska, 2003; Kutter et al. 
2000; Matsuzaka et al. 2008; Nagatomi, 2006; Pütsep et al. 2002). This demonstrates the 
need to study other aspects of immunity to further clarify the effects of SIT on human 
immune function. Hence, the purpose of the present study was to explore the acute effects of 
Wingate-based SIT on selected immunological parameters including key aspects of innate 
  
immunity. A number of mechanisms have been implicated in the acute immunodepressive 
effects that occur following endurance exercise, including the direct and indirect effects of 
stress hormones, the premature release of functionally sub-mature leukocytes from the bone 
marrow, substrate depletion, and oxidative stress (Davison & Gleeson, 2007; Gleeson, 2007). 
It is likely that SIT will be associated with high physiological and oxidative stress responses 
but the duration of body tissue exposure will be less when compared with prolonged 
endurance exercise. Taken together with the fact that carbohydrate and glycogen depletion is 
unlikely to occur during SIT, to the extent seen with prolonged exercise, it was hypothesised 
that there will be little or no negative exercise-induced immunodepression following a single 
session of SIT.  
 
Materials and Methods 
 
This study was conducted according to the guidelines laid down in the Declaration of 
Helsinki and in accordance with the Human Tissue Act. All procedures were approved by 
Aberystwyth University Research Ethics Committee for research involving human 
participants. Written informed consent was obtained from all subjects. Subjects also 
completed a pre-exercise screening questionnaire (Physical Activity Readiness 
Questionnaire) before participating in each test. 
 
Subjects  
Nine healthy recreationally active men (age 27 ± 5 years, body mass 74 ± 11 kg, stature 1.8 ± 
0.1 m; means ± standard deviation) participated in this study. All of the volunteers had 
previously experienced the Wingate test but none had undertaken repeated Wingate tests or 
other SIT in the prior month. All subjects took part in a resting control trial, a familiarisation 
  
trial and a SIT trial. The familiarisation trial was conducted first and then the main 
experimental trials (resting control and SIT) were conducted in a counterbalanced crossover 
design (as n = 9 there was not a perfect balance: 5 subjects undertook the control first and 4 
undertook the SIT first). All trials were separated by at least 1 week.  
 
Testing protocols 
The familiarisation trial was designed to familiarise subjects to the testing procedures and 
performing more than one Wingate test. It consisted of 2 × 30-second Wingate tests separated 
by 4 minutes of recovery. The SIT trial consisted of 4 repeated tests (4 × 30-second Wingate 
tests) with 4 minute recovery intervals.  
 
Main trials 
Subjects were instructed to consume 500 ml of water 2 h pre-exercise before arrival at the 
laboratory on the morning of the main trials. All subjects were requested to arrive between 
08:30 and 09:30 (each subject at precisely the same time for each trial), after an overnight 
fast of at least 10 h.  On arrival at the laboratory, they were asked to swill and rinse their 
mouth with plain water before sitting on a phlebotomy chair for 10 minutes. After 10 minutes 
of rest, blood and saliva samples were obtained before the subjects were provided with a 
drink of plain water (300 ml). For the resting control trial subjects remained seated and 
further samples were collected at times equivalent to post-exercise and 30-minutes post-
exercise in the exercise trials (see below). For the exercise (SIT) trials, subjects remained 
seated for a few minutes before mounting the cycle ergometer (Lode Excalibur Sport, Lode, 
Groningen, The Netherlands). They performed a warm-up consisting of 5 minutes at 50 W 
ZLWKDVHFRQGµVSULQW¶DWPLQXWHVDQGPLQXWHVUHVWEHIRUHEHJLQQLQJWKHUHSHDWHG
Wingate tests. A total of 4 Wingate tests were performed. Strong verbal encouragement was 
  
provided during each Wingate test. Subjects remained on the ergometer during the recovery 
intervals and were encouraged to maintain a cadence of between 60 and 80 rpm (with the 
ergometer set to 0 W). After completing the last test, subjects were instructed to maintain a 
pedal cadence of 60-80 rpm for 2 minutes before returning to the chair for samples to be 
collected. In all cases the post-exercise blood samples were collected within 5 minutes of 
exercise and saliva samples within 8 minutes. Final blood and saliva samples were obtained 
at 30 minutes post-exercise so that all 3 samples (Pre-Ex, Post-Ex and 30 min Post-Ex) were 
approximately 30 minutes apart.  
 
Control  procedures 
Subjects completed a weighed food record diary for the 24 h period before the first trial and 
were required to follow the same diet before the subsequent trial. Subjects were all non-
smokers, not currently (or within the prior 4 weeks) taking any medication or nutritional 
supplements (including viWDPLQPLQHUDORUµVSRUWV¶VXSSOHPHQWV7KH\ZHUHDOVRrequired to 
abstain from alcohol, caffeine and strenuous activity for 48 h prior to each trial.  
 
Blood samples 
Blood samples were obtained by venepuncture, with minimal stasis, from an antecubital vein 
and collected into vacutainer tubes (4.5 ml into a K3EDTA treated tube and 6 ml into a 
heparin treated tube). An initial resting (Pre-Ex) sample was obtained before exercise (or at 
the equivalent time in the resting control trial). Further venous blood samples were taken 
immediately after completion of the SIT exercise bout (Post-Ex) and after 30 minutes of 
recovery (30 min Post-Ex), or at equivalent times in the resting control trial, during which 
subjects remained in the laboratory and were allowed to undertake restful activities such as 
reading or using a computer. All blood samples were obtained while subjects were in the 
  
seated position. Subjects were asked to sit without changes of posture and minimal movement 
for 10 minutes before all blood samples were drawn, except the Post-Ex sample, which was 
drawn as soon as possible after completing the exercise (within 5 minutes). 
 
Saliva samples 
Saliva samples were collected as previously described (Davison & Diment, 2010), at Pre-Ex, 
Post-Ex, and 30 min Post-Ex. Briefly, timed, unstimulated whole saliva was obtained whilst 
subjects were seated, with the eyes open and head tilted slightly forward and making minimal 
orofacial movement. They were asked to swallow to empty the mouth, before whole saliva 
was collected by passive dribble into a pre-weighed sterile tube for an initial period of 2 
minutes. If insufficient saliva was obtained after the initial 2-minute period the process was 
repeated. Subjects were not allowed to drink for at least 10 minutes prior to each sample. The 
tube was re-weighed after collection of the sample so that saliva volume (and hence flow 
rate) could be estimated. Tubes were weighed to the nearest 0.1 mg (saliva density was 
assumed to be 1.0 g.ml-1) and aliquots were frozen, at ±Û&IRUODWHUDQDO\VLV 
 
Analytical methods 
All analyses were conducted in duplicate unless otherwise stated. 
 
Blood analysis. Haematological analysis was performed on the blood samples collected into 
the K3EDTA tubes using an automated haematology analyser (ABX Pentra 60C+, Horiba 
Medical, Montpellier, France). Blood haemoglobin concentration, haematocrit, total and 
differential leukocyte counts were measured. Haematocrit was also determined (in triplicate) 
by standard micro-centrifugation (with a Hawksley micro-centrifuge) for use, along with 
haemoglobin concentration, to estimate post-exercise changes in plasma volume using the 
  
equations of Dill and Costill (1974). Blood lactate and glucose concentrations were 
determined in heparinised blood using an automated analyser (YSI 2300 Stat Plus, Yellow 
Springs, OH, USA).  
 
One ml aliquots of whole blood were separated for the measurement of in vitro-stimulated 
neutrophil oxidative burst and ex vivo reactive oxygen species (ROS) (K3EDTA samples) and 
degranulation (Heparin samples) as detailed below. The remaining blood was centrifuged at 
1500 × g for 10 minutes DWÛ&DQGDOLTXRWVRISODVPDZHUHVWRUHGDW±Û&IRUODWHUDQDO\VLV
of plasma cortisol, Thiobarbituric acid reactive substances (TBARS) (K3EDTA tube), 
elastase and antioxidant capacity (heparin tube). All samples were thawed only once prior to 
analysis. Plasma cortisol concentration was determined using a commercially available 
enzyme linked immunosorbent assay (ELISA) kit (DRG, Germany; Biomercia, Ca, USA); 
TBARS was assessed with a commercially available colorimetric assay kit (QuantiChrom, 
BioAssay Systems, CA, USA) with Malondialdehyde (MDA) as the standard, giving results 
in MDA equivalent units (ȝM); and plasma antioxidant capacity was assessed with a 
chemiluminescence assay (ABEL-21M2, Knight Scientific, Plymouth, UK), with ascorbate 
as the standard, giving results in ascorbate equivalent units (ȝM). All samples were thawed 
only once prior to analysis. 
 
In vitro stimulated neutrophil oxidative burst. The neutrophil oxidative burst activity 
(OBA) response to phorbol-12-myristate-13-acetate (PMA) and formyl-leucyl-methionyl-
phenylalanine (fMLP) were determined as previously described (Davison and Gleeson, 2006) 
using a commercially available chemiluminescence kit (ABEL-04M, Knight Scientific, 
Plymouth, UK). Briefly, chemiluminescence was measured in a microplate luminometer 
(FLUOstar OPTIMA, BMG Labtech, Offenburg, Germany) reading samples in microplate 
  
ZHOOV(DFKZHOOFRQWDLQHGȝOZKROHEORRG.3EDTA anticoagulated) diluted 1:100 with 




for 30 secondsLQWKHOXPLQRPHWHUEHIRUHȝORI30$ȝJPO-1), fML3ȝ0RUDVVD\
buffer (as the XQVWLPXODWHGFRQWUROZDVLQMHFWHGJLYLQJDWRWDOYROXPHRIȝOSHUZHOODQG
DILQDOFRQFHQWUDWLRQRIȝJPO-1 30$RUȝ0I0/3IRUVWLPXODWHGVDPSOHV:KHQ30$
was used chemiluminescence was recorded in duplicate as relative light units (RLU) per 
second at 20-second intervals for 30 minutes. For fMLP, chemiluminescence was measured 
every 2 seconds for 5 minutes. Additionally, after a further 5 minutes, ȝORIPMA was 
injected into the samples that had previously been stimulated with fMLP (fMLP-then-PMA-
stimulated) to activate the non-receptor dependent OBA HJ)LJXUH%$QRWKHUȝORI
assay buffer was also injected into the control wells to maintain the same relative 
concentration in stimulated and unstimulated samples. Neutrophil OBA was expressed in 2 
ways: 1) as the stimulated-area under curve, in which the integral of the stimulated 
chemiluminescence curve was calculated and the integral of the unstimulated control curve 
(chemiluminescence response without stimulation) was subtracted; 2) as the stimulated-peak 
chemiluninescnece (peak stimulated minus unstimulated chemiluninescnece at the equivalent 
time). It was assumed that the chemiluminescence response depends almost entirely on 
neutrophils (Morozov et al. 2003) therefore the chemiluminescence responses were divided 
by the number of neutrophils per well in order to express OBA per neutrophil.  
 
*** please insert Figure 1 near here *** 
 
  
Ex vivo reactive oxygen species. Whole blood (predominantly from leukocytes) may 
contribute to exercise-induced elevations in excess ROS and oxidative stress (Nikolaidis and 
Jamurtas, 2009; Powers and Jackson, 2008). Therefore, the unstimulated (control) 30-minute 
chemiluminescence responses from the neutrophil oxidative burst assay were also expressed 
per ȝOof whole blood to give a measure of spontaneous chemiluminescence (a snapshot of 
the level of ROS) present in the blood at that time.  
 
In vitro stimulated neutrophil degranulation. The neutrophil degranulation response to 
bacterial stimulant (840-15, Sigma, Poole, UK) was determined as previously described 
(Davison and Diment, 2010). Neutrophil degranulation was expressed as the amount of 
stimulated elastase release per neutrophil (in 1 hour, whilst incubated at 37°C). Elastase 
concentration was determined using a commercially available ELISA kit (Merck 
Calibiochem, Darmstadt, Germany). 
 
Salivary analysis. Saliva analysis was conducted as previously described (Davison and 
Diment, 2010). All samples were thawed only once prior to analysis. After thawing, at room 
temperature, samples were centrifuged at 15000 × g for 2 minutes to pellet debris, precipitate 
mucins and obtain a clear supernatant. Saliva osmolality was determined using a freezing 
point depression osmometer (Osmomat 030, Gonotec, GbBH, Berlin, Germany) calibrated 
with 300 mOsmol.kg-1 salLQHVROXWLRQLQDFFRUGDQFHZLWKWKHPDQXIDFWXUHU¶VLQVWUXFWLRQV
Accuracy was confirmed with a 50 mOsmol.kg-1 reference solution. Saliva samples were 
screened for blood contamination by the measurement of salivary transferrin concentration 
using a commercially available ELISA kit (Salimetrics, PA, USA). Blood contamination was 
assumed if salivary transferrin concentration exceeded 1.0 mg.dl-1. In the event that blood 
contamination was detected, all salivary data for that subject were excluded from the 
  
analysis. Aliquots of saliva were analysed for the determination of secretary IgA (s-IgA) 
(Salimetrics, PA, USA) and Lysozyme (Biomedical Technologies Inc., MA, USA) using 
commercially available ELISA kits. 
 
Statistical Analysis. 
Statistical analyses were carried out using the statistical software package SPSS (v17.00; 
SPSS Inc., IL, USA). All data except saliva lysozyme secretion rate were normally 
distributed. Saliva lysozyme secretion rate data were normalised with log transformation 
before statistical analysis. To compare the responses between trials (resting control and SIT) 
a 2-way repeated measures ANOVA (trial × time) was used, with post hoc Student's paired t 
tests (Holm-Bonferroni corrected) where appropriate. When there was evidence of an 
interaction the effect of time was analysed in each group independently, with 1-way repeated 
measures ANOVA and post hoc Student's paired t tests (Holm-Bonferroni corrected) where 
appropriate. The Greenhouse-Geisser correction was applied, to correct for violations of the 
assumption of sphericity, where necessary (indicated in the text by GH following the P value 




*** please insert Table  1 near here *** 
The average peak power output during each repetition of the Wingate test decreased 
progressively throughout the SIT trial: rep 1, 830 r 78 W; rep 2, 786 r 69 W (6WXGHQW¶V
paired t test P =  0.04 vs. rep 1); rep 3, 720 r 77 W (P = 0.003 vs. rep 1); rep 4, 683 r 111 W 
(P = 0.002 vs. rep 1). The average Wingate mean power output during each repetition also 
followed the same general pattern: rep 1, 557 r 26 W; rep 2, 533 r 46 W (P = 0.021 vs. rep 
  
1); rep 3, 464 r 45 W (P = 0.002 vs. rep 1); rep 4, 447 r 58 W (P = 0.002 vs. rep 1). 
Estimations of plasma volume change showed a significant trial × time interaction (Table 1). 
There were significant decreases in plasma volume at both post-exercise time points but the 
magnitude of the post-exercise decrease was greater on the SIT compared with resting control 
trials: decreases of 0.7% vs. 19.8% at Post-Ex, and 2.2% vs. 10.0% at 30 min Post-Ex in the 
control and SIT trials, respectively. A significant trial × time interaction indicated that the 
temporal response of blood lactate concentration was different between trials. There was a 
significant increase in blood lactate concentration Post-Ex, which remained at 30 min Post-
Ex, in the SIT trial (Table 1). There was no trial × time interaction for blood glucose 
concentration but there was a slight decrease by the 30 min Post-Ex time point (Table 1). 
Trial × time interaction effects (P <  0.001) were evident for plasma cortisol concentration 
and blood neutrophil count. Post hoc analysis revealed post-exercise increases in plasma 
cortisol concentration in the SIT trial, contrasting to the decrease over time observed in the 
control trial (Table 2). Post hoc analysis for blood neutrophil count revealed post-exercise 
increases in the SIT trial whereas there was no change in the control trial (Table 2).  
 
*** please insert Table 2 near here *** 
 
The OBA results, whether expressed as the chemiluniescence curve integral or peak, gave 
equivalent results (in terms of magnitude and direction of changes during, and comparisons 
between, rest or in response to exercise) so only the area under curve data are presented. There 
were significant trial × time interactions for fMLP-stimulated (P = 0.044), and PMA-
stimulated (P < 0.001) OBA, but not for fMLP-then-PMA-stimulated OBA (P = 0.140). Post 
hoc analyses revealed no change in the control trial for fMLP-stimulated or PMA-stimulated 
OBA, whereas there were significant post-SIT decreases at 30 min Post-Ex (P = 0.008) for 
  
fMLP-stimulated OBA and at Post-Ex (P = 0.008) and 30 min Post-Ex (P = 0.002) for PMA-
stimulated OBA (Figure 2). There was a significant trial × time interaction for stimulated 
neutrophil degranulation (P = 0.011). Post hoc analyses revealed no change in the control 
trial and significant decreases at Post-Ex (P = 0.009) and 30 min Post-Ex (P = 0.006) in the 
SIT trial (Figure 3).  
 
*** please insert Figure 2 near here *** 
 
Blood contamination was detected in at least one saliva sample (rest and/or post-exercise) of 
3 subjects. Data for these subjects were excluded leaving n = 6 for all saliva parameters. 
There was a significant trial × time interaction for saliva flow rate (control: Pre-Ex 0.34 r 
0.26 ml.min-1, Post-Ex 0.32 r 0.17 ml.min-1, 30 min Post-Ex 0.38 r 0.29 ml.min-1; SIT: Pre-
Ex 0.48 r 0.18 ml.min-1, Post-Ex 0.26 r 0.08 ml.min-1, 30 min Post-Ex 0.38 r 0.18 ml.min-1, 
trial × time interaction P = 0.009), and post hoc analysis revealed a significant Post-Ex 
decrease (P = 0.018) in the SIT trial (with no change in the control trial). There was a 
significant trial × time interaction for saliva osmolality (control: Pre-Ex 53 r 9 mOsmol.kg-1, 
Post-Ex 56 r 7 mOsmol.kg-1, 30 min Post-Ex 58 r 5 mOsmol.kg-1; SIT: Pre-Ex 59 r 13 
mOsmol.kg-1, Post-Ex 101 r 17 mOsmol.kg-1, 30 min Post-Ex 94 r 16 mOsmol.kg-1, trial × 
time interaction P = 0.008), and post hoc analysis revealed a significant Post-Ex increase (P < 
0.001 Post-Ex and P = 0.012, 30 min Post-Ex) in the SIT trial (with no change in the control 
trial). There was a trial × time interaction for salivary s-IgA concentration, which increased at 
the post-exercise times in both trials but to a greater extent in the SIT trial (Table 2). There 
was no interaction for salivary s-IgA:osmolality ratio and for salivary s-IgA secretion rate. 
Saliva s-IgA:osmolality ratio was elevated above Pre-Ex only at the Post-Ex time (in both 
trials, Table 2) and salivary s-IgA secretion rate was elevated at both post-exercise time 
  
points. There was a trial × time interaction for salivary lysozyme concentration and post hoc 
analysis revealed no change in the control trial whereas there was a significant increase at the 
post-exercise times in the SIT trial (Table 2). There was no main interaction or time effects 
for salivary lysozyme:osmolality ratio and for salivary lysozyme secretion rate (Table 2).  
 
*** please insert Figure 3 near here *** 
 
There was a significant trial × time interaction for plasma antioxidant capacity and post hoc 
analysis revealed no change in the control trial whereas there was a significant increase at the 
post-exercise times in the SIT trial (Table 3). There was a significant trial × time interaction 
for plasma TBARS concentration and post hoc analysis revealed no change in the control trial 
but a significant increase in the SIT trial (Table 3). Significant time and trial × time 
interaction effects were also observed for ex vivo ROS but post hoc analyses was unable to 
detect differences between any time points within or between trials.  
 




The main findings of the present study are that a single session of Wingate-based SIT causes 
significant immunodepression of some neutrophil functions (oxidative burst and 
degranulation) but not mucosal immunity (salivary lysozyme and s-IgA concentration and 
secretion rate). The magnitude of the exercise-induced depression of some neutrophil 
functions (e.g. OBA) is comparable with previous studies, using the same methods, in which 
prolonged endurance exercise (> 2 h duration) was employed (Davison and Gleeson, 2005, 
  
2006). However, the magnitude of the exercise-induced depression of neutrophil 
degranulation is considerably smaller than the changes observed in these studies (Davison 
and Gleeson, 2005, 2006), although similar to the changes observed following a 2 h protocol 
(Davison and Diment, 2010). However, such comparisons are made with caution as it was not 
the main aim of the present study to directly compare SIT and prolonged endurance exercise. 
The main aim was to determine whether SIT induced significant immunodepression, and this 
was evident only for some markers of neutrophil function (fMLP-stimulated and PMA-
stimulated OBA and bacterial-stimulated degranulation). Additionally, the observation that 
SIT did not induce a significant decrease of fMLP-then-PMA-stimulated OBA, salivary s-
IgA or lysozyme (whether salivary parameters were expressed as an absolute concentration, 
normalised to saliva osmolality or expressed as the secretion rate) is in contrast to previous 
studies, which have demonstrated compromised mucosal immunity (Fahlman et al. 2001; 
Hall et al. 2007; MacKinnon and Jenkins, 1993).     
 
Previous research (Davison and Diment, 2010; Davison and Gleeson, 2005, 2006, 2007; 
Davison et al. 2007) has suggested that the decreased neutrophil functions observed 
following prolonged exercise are caused in part by the mobilisation of functionally immature 
neutrophils (Berkow and Dodson, 1986) from the bone marrow. The post-exercise increase in 
blood neutrophil count observed in the present study (< 2-fold) was modest by comparison 
with prolonged exercise of 2 to 2.5 h duration (in which there is typically an increase of 
between 3 and 6-fold post-exercise; Davison and Diment, 2010; Davison and Gleeson, 2005, 
2006, 2007; Davison et al. 2007). Furthermore, the increase in the present study may be 
partly accounted for by the post-exercise change in plasma volume. Therefore, it is unlikely 
that this mechanism can explain the depression of neutrophil functions observed in the 
present study. The post-exercise increase in plasma cortisol concentration observed in the 
  
present study is comparable with a previous study with prolonged exercise of 2 h duration 
(Davison and Diment, 2010) and this seems to be independent from the post-exercise change 
in plasma volume. However, greater cortisol responses have been observed with similar 
protocols, but with prolonged exercise of more than 2 h duration (Davison and Gleeson, 
2005, 2006, 2007; Davison et al. 2007). Taken together, this suggests that the SIT-induced 
decreases of neutrophil functions are caused by more direct mechanisms, such as the direct 
effects of stress hormones and oxidative stress, as discussed below.  
 
The present results for the OBA responses activated with various stimulants allows some 
insight into the possible mechanisms responsible for the SIT-induced depression of 
neutrophil OBA. For example, fMLP activates oxidative burst by binding to receptors on the 
neutrophil cell membrane (receptor-dependent activation of OBA). This initiates an 
intracellular signalling cascade, ultimately leading to the assembly of NADPH oxidase and 
activation of oxidative burst. PMA induces receptor-independent activation of OBA, by 
entering the cell (neutrophil) and directly activating protein kinase C (PKC), inducing the 
activation of NADPH oxidase and oxidative burst throughout the whole cell (also including 
the plasma membrane system). Since fMLP acts solely on the NADPH oxidase system of the 
plasma membrane, when PMA is used as the stimulant subsequent to stimulation with fMLP 
(e.g. Figure 1B), the (fMLP-then-PMA) chemiluminescence response represents the capacity 
for OBA remaining after the cell surface (fMLP-VWLPXODWHGV\VWHPKDVEHHQµGLVFKDUJHG¶
Hence, this provides a representation of completely non-receptor-dependent OBA capacity.  
 
In the present study, there were significant SIT-induced decreases of receptor-dependent 
stimulated neutrophil functions (OBA and degranulation) but not the fMLP-then-PMA-
stimulated OBA. Taken together, these findings suggest that the SIT-induced effects on 
  
neutrophil dysfunction are associated with direct mechanisms acting at the cell surface, 
although this requires further research. Support for this idea has been previously suggested, 
for prolonged exercise (Davison and Gleeson, 2007; Robson et al. 2003), in which a plausible 
µGLUHFW¶mechanism is the exercise-induced production of excess free radicals and ROS, 
which may lead to oxidative stress or damage to neutrophils, since the membrane receptors 
are more exposed to extracellular attack by ROS. These studies (Davison and Gleeson, 2007; 
Robson et al. 2003) provide strong evidence for the ROS-mediated theory as they also 
demonstrated that the exercise-induced alterations in neutrophil function and oxidative stress 
markers were blunted by the administration of antioxidants. The present findings, that the 
receptor-dependent activation was affected by SIT whereas the receptor-independent 
activation was not, provide preliminary support for this but further work is required, 
including studies with antioxidant administration and studies of in vitro exposure of 
neutrophils to ROS, to determine whether these theorised mechanisms are correct. However, 
the observed post-exercise increase in plasma TBARS and antioxidant mobilization add 
further weight to the argument that SIT-induced neutrophil dysfunction is mediated, at least 
in part, by oxidative stress to these cells.  
 
Salivary s-IgA and lysozyme concentrations were significantly increased following SIT. This 
may be largely due to the pseudo-concentrating effects induced by strenuous exercise and 
high ventilation rates (such as changes in hydration status, mucosal drying and evaporative 
loss of water). For example, when these analytes were normalised, by expressing them 
relative to saliva osmolality or as the secretion rate, the exercise-induced increases were 
markedly reduced or absent (Table 2). The present results for salivary lysozyme are in 
agreement with previous studies (Allgrove et al. 2008; West et al. 2010) in which continuous 
strenuous exercise (of up to ~30 minutes) has been shown to increase the salivary 
  
concentration or secretion of antimicrobial proteins. While this may be viewed as a 
potentially beneficial response, it may actually be a result of physical damage to epithelial 
cells in the upper airways, and subsequent inflammatory responses, meaning that the 
immunological and host defence implications are unclear at present (Gleeson, 2007; West et 
al. 2010).  In addition, it is possible that repeated stimulation of such responses during 
periods of intensive training are involved in the chronic lowering that has been observed for 
the salivary concentration and secretion rate of these proteins of innate immunity during 
prolonged training periods (West et al. 2010). However, such a link between the acute 
salivary antimicrobial proteins responseVWRVWUHQXRXVH[HUFLVHDQGµFKURQLF¶WUDLQLQJeffects 
requires further investigation. 
 
The discrepancy between the findings of the present study and previous research (Fahlman et 
al. 2001; Hall et al. 2007; MacKinnon and Jenkins, 1993) for salivary s-IgA responses to SIT 
may be due to differences in methodology and the subject population. For example, it has 
been shown (although with a maximal treadmill protocol) that males exhibited an acute 
increase in salivary s-IgA post-exercise whereas females exhibited a decrease (Schouten et al. 
1988). Hence, the difference between the present findings, with all male subjects, and the 
exercise-induced decrease observed by Fahlman et al. (2001) may be explained by the fact 
that the subjects in the latter study were all female. Likewise, the sex of the subjects was not 
reported in the study by Hall et al. (2007) so it is possible that there was a mixture of males 
and females. Finally, the study by MacKinnon and Jenkins (1993) employed a protocol with a 
higher total volume of exercise (5 × 60-second Wingate tests), which may explain why a 
post-exercise decrease was observed.  
 
Conclusions and future directions  
  
Research evidence showing the many potential benefits of SIT could lead to increased use of 
this type of training, both as a research tool and practically in sporting and athletic 
populations. The present study demonstrated that a single session of SIT caused significant 
exercise-induced immunodepression of key aspects of innate immunity (blood neutrophil 
OBA and degranulation capacity), which persisted for at least 30 minutes post-exercise. 
However, some of the measured parameters were not negatively affected (fMLP-then-PMA-
stimulated OBA, salivary s-IgA and lysozyme). These findings may have implications for 
those considering the incorporation of SIT into a training programme. However, it must be 
acknowledged that the SIT protocol employed in the present study (a single session of 4 × 
30-second Wingate tests) was based on the first day of the 2-week protocol from the 
McMaster group (i.e. Burgomaster et al. 2006, 2007, 2008; Gibala et al. 2006) in subjects 
with limited prior experience of Wingate-based SIT. Therefore, future research in this area 
should determine the responses to repeated SIT sessions (e.g. over a typical 2-week SIT 
period), also in subjects with prior experience of SIT, and additionally determine the chronic 
responses when SIT is incorporated into a long-term training programme.  
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Table Headings and Legends 
 







Post-Ex 30 min Post-Ex 
2-way ANOVA 
Main Effects, P = 




   
 
0.001 ; < 0.001GH; < 0.001 GH 
Control - 0.7 (r 0.1) Á 2.2 (r 1.9)   
SIT 
 




    
< 0.001 ; < 0.001 ; < 0.001 
Control 0.8 (r 0.3) 0.9 (r 0.3) 0.9 (r 0.4)  
SIT 
 





* 0.946 ; 0.003 ; 0.085 
Control 4.7 (r 0.6) 4.4 (r 0.4) 4.2 (r 0.4)  
SIT 
 
4.7 (r 0.5) 4.7 (r 0.7) 3.9 (r 0.4) 
 
Values are mean (r standard deviation). Post hoc analysis for main effect of time: signifies a 
significant difference from Pre-Ex (either pooled data from both trials due to no interaction 
effect: *P < 0.05, **P < 0.01, or each trial independently when an interaction exists:  P <  0.05; Á
 P <  0.01). Post hoc analysis for trial × time interaction: signifies a significant difference, 




Table 2: Physiological stress and immunological responses 
 Pre-Ex Post-Ex 30 min Post-Ex 
2-way ANOVA 
Main Effects, P = 
(trial; time; interaction) 
Plasma [cortisol] 
(nM) 
    
0.002 ; < 0.001; < 0.001 
Control 330 (r 97) 276 (r 94) Á 246 (r 97) Á  
SIT 
 
367 (r 123) 507 (r 120)Áaa 641 (r 150)Áaa 
 
Blood neutrophil count 
(× 109 cells.l-1) 
   
 
0.039 ; < 0.001GH ; < 0.001 
Control 2.3 (r 0.9) 2.4 (r 0.9)  2.5 (r 1.0)   
SIT 
 
2.3 (r 0.7) 4.0 (r 1.5) Áaa 3.1 (r 1.0) Áa 
 
Saliva [s-IgA]  
(mg.l-1) 
  
 0.003 ; < 0.001 ; 0.005 
Control 148 (r 26) 190 (r 31)  182 (r 19) Á  
SIT 
 





*  0.640 ; 0.007 ; 0.499 
Control 2.8 (r 0.4) 3.4 (r 0.7) 3.2 (r 0.5)  
SIT 
 
2.7 (r 0.3) 3.8 (r 0.7) 3.2 (r 0.6) 
 
Saliva s-IgA secretion 
rate (µg.min-1) 
 
* * 0.033 ; 0.002 ; 0.696 
Control 47 (r 18) 60 (r 32) 66 (r 43)  
SIT 
 
76 (r 23) 99 (r 33) 106 (r 31) 
 
Saliva [Lysozyme]  
(mg.l-1) 
  
 0.040 ; 0.003 ; 0.035 
Control 10.5 (r 2.3) 11.6 (r 3.7) 13.9 (r 6.7)  
SIT 
 






 0.704 ; 0.128 ; 0.498 
Control 0.21 (r 0.07) 0.21 (r 0.09) 0.24 (r 0.12)  
SIT 
 






 0.341 ; 0.085 ; 0.446 
Control 3.6 (r 2.3) 3.8 (r 2.9) 6.1 (r 6.7)  
SIT 
 
6.1 (r 5.9) 6.8 (r 3.7) 9.7 (r 7.3) 
 
Values are mean (r standard deviation). Post hoc analysis for main effect of time: signifies a 
significant difference from Pre-Ex (either pooled data from both trials due to no interaction 
effect: *P < 0.05, **P < 0.01, or each trial independently when an interaction exists:  P <  0.05; Á
 P <  0.01). Post hoc analysis for trial × time interaction: signifies a significant difference, 
between trials, in the change from Pre-Ex (aaP < 0.01, aP < 0.05).  
 
  






Post-Ex 30 min Post-Ex 
2-way ANOVA 
Main Effects, P = 
(trial; time; interaction) 
Plasma antioxidant 
capacity 
(ȝM ascorbate equivalent) 
   
 
0.023 ; < 0.001; < 0.001
 GH 
Control 348 (r 55) 359 (r 53) 377 (r 52)  
SIT 
 




    
0.083 ; 0.022 ; 0.007 
Control 1.61 (r 0.64) 1.60 (r 0.62) 1.53 (r 0.63)  
SIT 
 
1.55 (r 0.54) 1.81 (r 0.48)  2.06 (r 0.43) a 
 
Blood ex vivo ROS  
 (% of Pre-Ex)    0.124 ; 0.003 ; 0.026 
Control 100 (-) 95 (r 9) 89 (r 13)  
SIT 100 (-) 117 (r 23) 94 (r 18)  
    
 
Values are mean (r standard deviation). Post hoc analysis for main effect of time: signifies a 
significant difference from Pre-Ex (each trial independently due to interaction:  P <  0.05; Á P <  
0.01). Post hoc analysis for trial × time interaction: signifies a significant difference, between 






Figure 1: Example of typical chemiluminescence (OBA) response with different stimulants. 
Panel A (left) shows a typical response after stimulation with PMA (and no stimulation control) and Panel B 
(right) shows a typical response after stimulation with fMLP and PMA subsequent to fMLP (fMLP-then-PMA). 
























Figure 2: Stimulated neutrophil OBA responses to SIT and Control trials.  
Top panel, fMLP-stimulated OBA; middle panel, PMA-stimulated OBA; bottom panel, fMLP-then-PMA-
stimulated OBA. Post hoc analysis for main effect of time: signifies a significant difference from Pre-Ex (for 
each trial independently when an interaction exists:  P <  0.05; Á P <  0.01). Post hoc analysis for trial × time 




Figure 3: Stimulated neutrophil degranulation responses to SIT and Control trials.  
Post hoc analysis for main effect of time: signifies a significant difference from Pre-Ex (for each trial 
independently when an interaction exists:  P <  0.05; Á P <  0.01). Post hoc analysis for trial × time interaction: 
signifies a significant difference, between trials, in the change from Pre-Ex (aaP <  0.01, aP <  0.05). 
 
